Skip to main content
Equibles
PHIO logo

PHIO · Phio Pharmaceuticals Corp. · Webcasts, Transcripts & Audio

Track PHIO — free

Use PHIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PHIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.89 +0.00 (+0.31%) At close · Oct 21
Rebalance outlook locked
Going-concern doubt — cleared Aug 6, 2026

The latest filing states the doubt was alleviated.

“The Company has limited cash resources, has incurred recurring operating losses and negative cash flows from its operations since its inception and has not yet recognized any product revenues. These factors have previously raised doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 6, 2026
Market Cap
$10.36M
Shares
11.62M
Volume · Oct 21 100.34K Avg daily vol (3M) 135.49K

Phio Pharmaceuticals Corp. Webcasts

Earnings calls, investor updates, investor days and conferences for Phio Pharmaceuticals Corp. (PHIO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Key facts CIK 1533040 CUSIP 71880W501 13F (30d) 2 filings 2 filers Visit website Investor relations